Amphastar Pharmaceuticals... (AMPH)
28.42
-0.08 (-0.28%)
At close: Mar 28, 2025, 3:59 PM
28.34
-0.28%
Pre-market: Mar 31, 2025, 04:18 AM EDT
Amphastar Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 151.61M | 144.3M | 156.1M | 126.35M | 92.64M | 73.69M | 86.34M | 65.59M | 72.35M | 66.07M | 67.83M | 53.59M | 50.21M |
| Short-Term Investments | 70.04M | 112.51M | 19.66M | 10.32M | 12.98M | 11.68M | 2.83M | 2.63M | 527K | 1.28M | 1.5M | n/a | n/a |
| Long-Term Investments | 11M | 15.21M | 2.41M | 3.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 25.99M | 25.91M | 20.86M | 16.66M | 5.25M | 11.16M | 9.92M | 8.66M | 9.39M | 4.7M | 3.59M | 2.88M | 2.04M |
| Receivables | 136.29M | 114.94M | 88.8M | 78.8M | 66M | 45.38M | 52.16M | 36M | 26.78M | 33.23M | 22.85M | 24.59M | 38.27M |
| Inventory | 153.74M | 105.83M | 103.58M | 92.81M | 96.83M | 110.5M | 69.32M | 63.61M | 79.75M | 70.67M | 82.33M | 69.92M | 51.38M |
| Other Current Assets | 22.4M | 12.02M | 17.73M | 9.84M | 11.23M | 14M | 9.69M | 19.94M | 4.68M | 5.96M | 24.98M | 24.88M | 25.82M |
| Total Current Assets | 534.07M | 489.6M | 378.32M | 318.12M | 279.68M | 255.24M | 220.34M | 187.78M | 184.1M | 175.93M | 198M | 172.97M | 165.69M |
| Property-Plant & Equipment | 344.63M | 315.64M | 264.57M | 271.49M | 280.71M | 253.55M | 210.42M | 185.34M | 152.94M | 142.16M | 138.29M | 116.62M | 107.37M |
| Goodwill & Intangibles | 590.66M | 613.29M | 37.3M | 38.87M | 40.62M | 41.15M | 42.27M | 45.14M | 50.31M | 39.9M | 42.56M | 40.16M | 42.35M |
| Total Long-Term Assets | 1.04B | 1.02B | 363.67M | 353.41M | 351.55M | 331.73M | 293.22M | 266.89M | 243.64M | 214.2M | 191.37M | 165.78M | 151.79M |
| Total Assets | 1.58B | 1.51B | 741.99M | 671.53M | 631.24M | 586.97M | 513.56M | 454.67M | 427.74M | 390.14M | 389.37M | 338.75M | 317.48M |
| Account Payables | 30.51M | 25.44M | 20.5M | 22.21M | 24.36M | 25.06M | 31.32M | 16.63M | 19.93M | 13.87M | 10.16M | 20.38M | 17.66M |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -56.09M | n/a | 97K | 643K | 14.01M | 643K | 642K |
| Short-Term Debt | 7.04M | 4.34M | 9.05M | 8.17M | 18.98M | 14.09M | 18.23M | 6.31M | 5.37M | 10.93M | 7.59M | 22.1M | 22.05M |
| Other Current Liabilities | 134.46M | 194.02M | 60.74M | 64.35M | 67.79M | 48.81M | 56.09M | 40.93M | 27.61M | 31.43M | 27.7M | 19.43M | 16.69M |
| Total Current Liabilities | 173.76M | 225.41M | 94.86M | 103.81M | 112.2M | 90.01M | 106.83M | 67.19M | 60.62M | 59.95M | 62.59M | 65.4M | 60.08M |
| Long-Term Debt | 41.88M | 619.3M | 96.53M | 99.48M | 51.65M | 55.71M | 31.98M | 40.84M | 32.36M | 30.16M | 36.11M | 10.07M | 15.95M |
| Other Long-Term Liabilities | 622.58M | 28.78M | 21.79M | 22.18M | 17.92M | 12.86M | 9.36M | 7.94M | 3.96M | 3.17M | 5.63M | 1.95M | 1.49M |
| Total Long-Term Liabilities | 671.41M | 648.08M | 118.47M | 122.2M | 70.31M | 69.43M | 42.37M | 50.14M | 37.87M | 34.67M | 44.91M | 21.8M | 23.96M |
| Total Liabilities | 845.17M | 873.49M | 213.33M | 226.01M | 182.51M | 159.44M | 149.2M | 117.34M | 98.48M | 94.63M | 107.51M | 87.2M | 84.04M |
| Total Debt | 48.92M | 623.64M | 102.58M | 104.66M | 67.27M | 66.63M | 50.21M | 47.16M | 37.72M | 41.1M | 43.7M | 32.17M | 38M |
| Common Stock | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K |
| Retained Earnings | 568.79M | 409.27M | 271.72M | 180.34M | 117.77M | 116.37M | 67.48M | 76.23M | 70.86M | 60.32M | 63.11M | 73.81M | 61.95M |
| Comprehensive Income | -9.18M | -8.48M | -8.62M | -6.76M | -3.72M | -4.69M | -4.01M | -2.1M | -4.7M | -2.48M | -1.65M | n/a | n/a |
| Shareholders Equity | 732.3M | 639.42M | 528.66M | 445.52M | 402.31M | 381.37M | 332.44M | 337.33M | 329.25M | 295.51M | 281.86M | 251.54M | 233.44M |
| Total Investments | 81.03M | 127.72M | 22.08M | 14.3M | 12.98M | 11.68M | 2.83M | 2.63M | 527K | 1.28M | 1.5M | n/a | n/a |